{"drugs":["Allfen","Cypex-LA","Guaifenesin\/Potassium Guaiacolsulfonate","Humibid L.A."],"mono":{"0":{"id":"927959-s-0","title":"Generic Names","mono":"Guaifenesin\/Potassium Guaiacolsulfonate"},"1":{"id":"927959-s-1","title":"Dosing and Indications","sub":{"0":{"id":"927959-s-1-4","title":"Adult Dosing","mono":"<b>Cough:<\/b> sustained-release, 1 tablet (1000 mg guaifenesin, 150 mg potassium guaiacolsulfonate) ORALLY every 12 h "},"1":{"id":"927959-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>safety and efficacy in children under 6 y of age have not been established<\/li><li><b>Cough:<\/b> (6 to 12 y) sustained-release, 1\/2 tablet (500 mg guaifenesin, 75 mg potassium guaiacolsulfonate) ORALLY every 12 h<\/li><li><b>Cough:<\/b> (12 y and older) sustained-release, 1 tablet (1000 mg guaifenesin, 150 mg potassium guaiacolsulfonate) ORALLY every 12 h<\/li><\/ul>"},"3":{"id":"927959-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Cough<br\/>"}}},"3":{"id":"927959-s-3","title":"Contraindications\/Warnings","sub":[{"id":"927959-s-3-9","title":"Contraindications","mono":"hypersensitivity to guaifenesin or potassium guaiacolsulfonate<br\/>"},{"id":"927959-s-3-10","title":"Precautions","mono":"<ul><li>underlying cause of cough should be determined prior to initiating therapy<\/li><li>increased risk of drug-induced kidney stone formation (guaifenesin)<\/li><\/ul>"},{"id":"927959-s-3-11","title":"Pregnancy Category","mono":"<ul><li>Guaifenesin: C (FDA)<\/li><li>Guaifenesin: A (AUS)<\/li><li>Potassium Guaiacolsulfonate: Unknown<\/li><\/ul>"},{"id":"927959-s-3-12","title":"Breast Feeding","mono":"<ul><li>Guaifenesin: Micromedex: Infant risk cannot be ruled out.<\/li><li>Potassium Guaiacolsulfonate: Unknown<\/li><\/ul>"}]},"5":{"id":"927959-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Gastrointestinal:<\/b>Nausea, Vomiting<br\/><b>Serious<\/b><br\/><b>Renal:<\/b>Nephrolithiasis, Large quantity consumption<br\/>"},"6":{"id":"927959-s-6","title":"Drug Name Info","sub":{"0":{"id":"927959-s-6-17","title":"US Trade Names","mono":"<ul><li>Cypex-LA<\/li><li>Humibid L.A.<\/li><li>Allfen<\/li><\/ul>"},"2":{"id":"927959-s-6-19","title":"Class","mono":"Expectorant<br\/>"},"3":{"id":"927959-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"927959-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"9":{"id":"927959-s-9","title":"Administration","mono":"<b>Oral<\/b><br\/>(sustained-release tablet) do not crush or chew <br\/>"},"10":{"id":"927959-s-10","title":"Monitoring","mono":"reduced cough, cough productivity<br\/>"},"11":{"id":"927959-s-11","title":"How Supplied","mono":"<b>Humibid LA<\/b><br\/>Oral Tablet, Extended Release: (Guaifenesin - Potassium Guaiacolsulfonate) 600 MG-300 MG<br\/>"},"13":{"id":"927959-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause nausea or vomiting.<\/li><li>Patients should report signs\/symptoms of nephrolithiasis, especially if ingesting large quantities. Do not take more than prescribed.<\/li><\/ul>"}}}